J2H Biotech: Clinical Trials

3 trials sponsored by J2H Biotech, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow J2H Biotech: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH
J2H-1702, Placebo - Non-alcoholic Steatohepatitis
Phase 2CompletedJ2H Biotech872023-02-152026-07-30
Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females
Amg dose administration group, Amg dose administration group- Placebo, Bmg dose administration group - Non-alcoholic Steatohepatitis
Phase 1CompletedJ2H Biotech162023-01-022025-12-17
Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males
Single administration Amg dose Group, Single administration Bmg dose Group, Single administration Cmg dose Group - Non-alcoholic Steatohepatitis
Phase 1CompletedJ2H Biotech1002020-08-122025-12-17

Conditions studied

Non-alcoholic Fatty Liver Disease (3)

Countries

South Korea (3)